跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
全球衛生暨衛生安全碩士學位學程
臺北醫學大學
公共衛生學院
電話
+886-2-27361661#6626
電子郵件
[email protected]
網站
https://global.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(12)
專案
(99)
研究成果
(1919)
資料集
(58)
指紋
查看啟用 全球衛生暨衛生安全碩士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Analgesia
5%
Anemia
5%
Apoplexy
25%
Brain Ischemia
12%
Breast Cancer
25%
Cancer Risk
5%
Cardiovascular Disease
7%
Case-Control Study
7%
Cesarean Section
5%
Childbirth
7%
Chronic Kidney Disease
16%
Cigarette Smoking
5%
Closed Head Injury
6%
Cohort Analysis
32%
Cohort Effect
8%
COVID-19
12%
Cross Sectional Study
8%
Diabetes
15%
Diabetes Mellitus
7%
Dietary Pattern
8%
Disease
24%
Drug Therapy
8%
Effect Size
5%
Global Disease Burden
6%
Hazard Ratio
13%
Health Care
9%
Health Care Cost
10%
Hepatocellular Carcinoma
10%
Hernioplasty
5%
Human Immunodeficiency Virus
5%
Infection
21%
Injury
16%
Ischemic Heart Disease
6%
Kidney Function
6%
Logistic Regression Analysis
10%
Lung Cancer
5%
Malignant Neoplasm
21%
Maturity Onset Diabetes of the Young
7%
Medicine
7%
Meta-Analysis
100%
Middle Age
5%
Neoplasm
7%
Network Meta-Analysis
10%
Odds Ratio
21%
Overall Survival
5%
Postoperative Pain
7%
Prevalence
20%
Programmed Cell Death
6%
Proportional Hazards Model
5%
Quality of Life
7%
Random Effects Model
7%
Randomized Controlled Trial
64%
Rehabilitation Engineering
5%
Retrospective Cohort Study
5%
Supplementation
5%
Surgeon
8%
Surgery
6%
Survival Rate
6%
Symptom
7%
Systematic Review
72%
Toxocariasis
5%
Traditional Chinese Medicine
5%
Traumatic Brain Injury
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
10%
Anti-Inflammatory Drug
9%
Antiinflammatory Activity
8%
Antioxidant
9%
Antivirus Agent
9%
Biological Marker
5%
Bladder Cancer
7%
Brain Ischemia
11%
Breast Cancer
20%
Cardiovascular Disease
8%
Carotid Atherosclerosis
7%
Case-Control Study
6%
Chemotherapy
7%
Chronic Kidney Failure
17%
Chronic Obstructive Lung Disease
5%
Cigarette Smoking
9%
Clinical Trial
5%
Cohort Study
44%
Comorbidity
8%
Cyclooxygenase 2
6%
Cytokine
5%
Cytotoxicity
10%
Diabetes Mellitus
10%
Disease
31%
Dose-Response Relationship
7%
Head Injury
7%
Headache
6%
Hemodialysis
6%
Hepatitis C
6%
Hepatitis C Virus
9%
HIV
6%
IC50
6%
Inducible Nitric Oxide Synthase
6%
Infection
19%
Inflammation
12%
Injury
15%
Ischemic Heart Disease
7%
Lipopolysaccharide
8%
Liver Cell Carcinoma
15%
Lung Cancer
8%
Lycium barbarum
6%
Malignant Neoplasm
33%
Migraine
6%
Mortality Rate
7%
Mouse
20%
Neoplasm
10%
Non Insulin Dependent Diabetes Mellitus
8%
Overall Survival
8%
Placebo
7%
Polysaccharide
6%
Prevalence
18%
Random Effects Model
7%
Randomized Controlled Trial
51%
Rheumatoid Arthritis
8%
Survival Rate
7%
Symptom
7%
Traditional Chinese Medicine
6%
Transitional Cell Carcinoma
7%
Traumatic Brain Injury
7%
Tumor Necrosis Factor
6%
Vaccination Policy
6%
Well Water
12%
Nursing and Health Professions
Breast Cancer
17%
Case-Control Study
5%
Chronic Kidney Failure
6%
Clinical Practice
5%
Cochrane Library
11%
Cohort Analysis
20%
Comorbidity
6%
Confidence Interval
45%
Cross-Sectional Study
10%
Disease
14%
Drug Therapy
12%
Embase
6%
Hazard Ratio
6%
Head Injury
8%
Health Care Personnel
12%
Health Literacy
8%
Health Service
13%
Health Status
5%
Hospital
12%
Human Immunodeficiency Virus
9%
Infection
6%
Injury
15%
Limb Injury
6%
Logistic Regression Analysis
9%
Long Term Care
6%
Malignant Neoplasm
8%
Medline
11%
Meta Analysis
78%
Mortality Rate
6%
Multivariate Logistic Regression Analysis
5%
National Health Insurance
16%
Odds Ratio
19%
Out of Hospital Cardiac Arrest
5%
Outpatient
6%
Practice Guideline
11%
Prevalence
11%
Public Hospital
5%
Quality of Life
13%
Rehabilitation Engineering
7%
Shared Decision-Making
7%
Symptom
8%
Systematic Review
47%
Teaching Hospital
6%
Traumatic Brain Injury
13%
World Health Organization
6%